Clinical trial Recruiting at 3 sites Interventional Ages 12 to 17

Online therapy for children and teens with body dysmorphic disorder

Official title: Clinical Efficacy and Cost-effectiveness of Internet-delivered Cognitive-behaviour Therapy for Children and Adolescents With Body Dysmorphic Disorder: a Randomised Controlled Trial

Run by Karolinska Institutet · NCT06262412 · Data updated 2026-11-12

This study is testing if an online therapy program can help children and teens with body dysmorphic disorder feel better compared to those who receive a relaxation treatment.

More Body Dysmorphic Disorders trials

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment154 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations3 sites (Gothenburg and 2 other locations)
StatusRecruiting
StartedFebruary 19, 2024
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedApril 30, 2026
Trial IDNCT06262412 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 12 to 17 with a primary diagnosis of body dysmorphic disorder and a symptom severity score of 24 or higher.

Probably not a fit

Patients with significant physical defects that are clearly noticeable may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness and cost-efficiency of a therapist-guided, Internet-delivered cognitive-behavior therapy (ICBT) program for children and adolescents diagnosed with body dysmorphic disorder (BDD). Participants will be compared to a control group receiving Internet-delivered relaxation treatment. The study aims to determine how well ICBT reduces BDD symptoms and assesses the durability of treatment effects over six months. Additionally, it will conduct a health-economic evaluation from various perspectives to understand the broader impact of ICBT.

Why it matters

Potential benefit: If successful, this therapy could provide accessible and effective treatment options for young individuals suffering from body dysmorphic disorder.

How similar studies have gone: Other studies have shown promise in using Internet-delivered cognitive-behavior therapy for various mental health conditions, suggesting potential success for this approach in treating BDD.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. A primary diagnosis of BDD, based on the diagnostic criteria of the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders. Confirmed by the assessor at the inclusion assessment using a semi-structured diagnostic interview. In cases where it is challenging to rule out the presence of actual physical defects that are clearly noticeable (e.g., if the area of concern is the genitalia), we will make a referral to an appropriate service for an expert opinion.
2. A total BDD symptom severity score on the BDD-YBOCS-A ≥24. Confirmed by the assessor at the inclusion assessment.
3. Age between 12 and 17 years. Confirmed by the caregiver/parent and subsequently by the medical record.
4. A minimum of one available caregiver/parent being able to co-participate and support the child/adolescent throughout the treatment. Confirmed by the caregiver/parent at the inclusion assessment.
5. Regular access to a computer connected to the Internet and a mobile phone to receive SMS messages (one of each per family is enough). Confirmed by the caregiver/parent at the inclusion assessment.

Exclusion Criteria:

1. Previous CBT for BDD for a minimum of five sessions with a qualified therapist within the 12 months prior to the inclusion assessment. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment and by the medical record.
2. Simultaneous psychological treatment for BDD or for any psychiatric comorbidity. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment and by the medical record.
3. Initiation, change of dosage or cessation of any selective serotonin reuptake inhibitors (SSRI) or antipsychotic drugs within the six weeks prior to the inclusion assessment. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment and by the medical record.
4. A diagnosis of organic brain disorder, intellectual disability, psychosis, bipolar disorder, eating disorder, severe depression or alcohol/substance dependence. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment, with supplemental information from the semi-structured diagnostic interview and by the medical record.
5. Immediate risk to self or others requiring urgent medical attention or inpatient care, such as suicidality, or repeated self-injurious behaviours. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment.
6. A documented suicide attempt in the last 12 months. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment or by documentation in the medical record.
7. Child/adolescent and caregiver/parent not able to read and communicate in Swedish. Confirmed by the caregiver/parent at the telephone screening and/or the inclusion assessment.
8. Having a close relationship to an already included participant (e.g., sibling, cousin), to avoid being randomised into two different arms, with the risk of information "leaking" between the groups. Confirmed by the caregiver/parent or assessor at the telephone screening and/or at the face-to-face or video conference inclusion assessment.

Where it's running

  • BUP Specialmottagning, Sahlgrenska Universitetssjukhuset
    Gothenburg, Sweden
    Recruiting
  • Barn- och ungdomspsykiatrin, Region Skåne
    Malmö, Sweden
    Recruiting
  • BUP OCD och relaterade tillstånd
    Stockholm, Sweden
    Recruiting

Study contacts

  • Principal investigator: Lorena Fernández de la Cruz, PhD — Department of Clinical Neuroscience (CNS), K8, CPF Mataix-Cols,
  • Study coordinator: Lorena Fernández de la Cruz, PhD
  • Email: lorena.fernandez.de.la.cruz@ki.se
  • Phone: +46 76 847 79 99

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Imagery rescripting treatment for OCD and BDD

    This study is testing a new therapy called imagery rescripting to see if it can help people with Obsessive Compulsive Disorder and Body Dysmorphic Disorder feel better and change their negative thoughts.

    Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam-Zuidoost, North Holland · NCT06346301

  • Testing dextromethorphan for treating OCD and related disorders

    This study is testing if adding a common cough medicine called dextromethorphan to the usual OCD treatment can help people with OCD and similar disorders feel better.

    Recruiting Phase 2 Stanford University · Stanford, California · NCT04899687

  • Using caloric vestibular stimulation to improve insight in obsessive-compulsive disorders

    This study is testing whether a special type of brain stimulation can help people with obsessive-compulsive disorders better understand their thoughts and behaviors to improve their treatment outcomes.

    Recruiting Stanford University · Stanford, California · NCT03918577

  • Understanding why some people benefit from cognitive behavioral therapy

    This study is trying to find out why some people with social anxiety and body dysmorphic disorder get better from cognitive behavioral therapy while others don’t, by looking at their brain scans and other information during treatment.

    Recruiting University of Washington · Seattle, Washington · NCT06678295

  • Understanding and Modifying Perceptual Distortions in Body Dysmorphic Disorder

    This study is testing if new visual techniques can help change the way people with body dysmorphic disorder see themselves and their appearance.

    Recruiting Centre for Addiction and Mental Health · Toronto, Ontario · NCT04373629

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.